Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Influenza, Human 2Central Nervous System Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × FluMist × Clear all
NCT00112112 2017-08-14

Safety Study to Evaluate FluMist in Immunocompromised Children

MedImmune LLC

Phase 1 Completed
20 enrolled 70 charts

Influenza, Human, Neoplasms

NCT00906750 2011-10-13

FMRESP

St. Jude Children's Research Hospital

Phase 1 Completed
56 enrolled

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡